Cargando…

Tissue pretreatment for LC–MS/MS analysis of PUFA and eicosanoid distribution in mouse brain and liver

Polyunsaturated fatty acids (PUFAs) and eicosanoids are important mediators of inflammation. The functional role of eicosanoids in metabolic-syndrome-related diseases has been extensively studied. However, their role in neuroinflammation and the development of neurodegenerative diseases is still unc...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinicke, Madlen, Dorow, Juliane, Bischof, Karoline, Leyh, Judith, Bechmann, Ingo, Ceglarek, Uta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118053/
https://www.ncbi.nlm.nih.gov/pubmed/31865417
http://dx.doi.org/10.1007/s00216-019-02170-w
_version_ 1783514478421213184
author Reinicke, Madlen
Dorow, Juliane
Bischof, Karoline
Leyh, Judith
Bechmann, Ingo
Ceglarek, Uta
author_facet Reinicke, Madlen
Dorow, Juliane
Bischof, Karoline
Leyh, Judith
Bechmann, Ingo
Ceglarek, Uta
author_sort Reinicke, Madlen
collection PubMed
description Polyunsaturated fatty acids (PUFAs) and eicosanoids are important mediators of inflammation. The functional role of eicosanoids in metabolic-syndrome-related diseases has been extensively studied. However, their role in neuroinflammation and the development of neurodegenerative diseases is still unclear. The aim of this study was the development of a sample pretreatment protocol for the simultaneous analysis of PUFAs and eicosanoids in mouse liver and brain. Liver and brain samples of male wild-type C57BL/6J mice (11–122 mg) were used to investigate conditions for tissue rinsing, homogenization, extraction, and storage. A targeted liquid chromatography–negative electrospray ionization tandem mass spectrometry method was applied to quantify 7 PUFAs and 94 eicosanoids. The final pretreatment protocol consisted of a 5-min homogenization step by sonication in 650 μL n-hexane/2-propanol (60:40 v/v) containing 2,6-di-tert-butyl-4-methylphenol at 50 μg/mL. Homogenates representing 1 mg tissue were extracted in a single step with n-hexane/2-propanol (60:40 v/v) containing 0.1% formic acid. Autoxidation was prevented by addition of 2,6-di-tert-butyl-4-methylphenol at 50 μg/mL and keeping the samples at 4 °C during sample preparation. Extracts were dried under nitrogen and reconstituted in liquid chromatography eluent before analysis. Recovery was determined to range from 45% to 149% for both liver and brain tissue. Within-run and between-run variability ranged between 7% and 18% for PUFAs and between 1% and 24% for eicosanoids. In liver, 7 PUFAs and 15 eicosanoids were quantified; in brain, 6 PUFAs and 21 eicosanoids had significant differences within the brain substructures. In conclusion, a robust and reproducible sample preparation protocol for the multiplexed analysis of PUFAs and eicosanoids by liquid chromatography–tandem mass spectrometry in liver and discrete brain substructures was developed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00216-019-02170-w) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7118053
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-71180532020-04-06 Tissue pretreatment for LC–MS/MS analysis of PUFA and eicosanoid distribution in mouse brain and liver Reinicke, Madlen Dorow, Juliane Bischof, Karoline Leyh, Judith Bechmann, Ingo Ceglarek, Uta Anal Bioanal Chem Research Paper Polyunsaturated fatty acids (PUFAs) and eicosanoids are important mediators of inflammation. The functional role of eicosanoids in metabolic-syndrome-related diseases has been extensively studied. However, their role in neuroinflammation and the development of neurodegenerative diseases is still unclear. The aim of this study was the development of a sample pretreatment protocol for the simultaneous analysis of PUFAs and eicosanoids in mouse liver and brain. Liver and brain samples of male wild-type C57BL/6J mice (11–122 mg) were used to investigate conditions for tissue rinsing, homogenization, extraction, and storage. A targeted liquid chromatography–negative electrospray ionization tandem mass spectrometry method was applied to quantify 7 PUFAs and 94 eicosanoids. The final pretreatment protocol consisted of a 5-min homogenization step by sonication in 650 μL n-hexane/2-propanol (60:40 v/v) containing 2,6-di-tert-butyl-4-methylphenol at 50 μg/mL. Homogenates representing 1 mg tissue were extracted in a single step with n-hexane/2-propanol (60:40 v/v) containing 0.1% formic acid. Autoxidation was prevented by addition of 2,6-di-tert-butyl-4-methylphenol at 50 μg/mL and keeping the samples at 4 °C during sample preparation. Extracts were dried under nitrogen and reconstituted in liquid chromatography eluent before analysis. Recovery was determined to range from 45% to 149% for both liver and brain tissue. Within-run and between-run variability ranged between 7% and 18% for PUFAs and between 1% and 24% for eicosanoids. In liver, 7 PUFAs and 15 eicosanoids were quantified; in brain, 6 PUFAs and 21 eicosanoids had significant differences within the brain substructures. In conclusion, a robust and reproducible sample preparation protocol for the multiplexed analysis of PUFAs and eicosanoids by liquid chromatography–tandem mass spectrometry in liver and discrete brain substructures was developed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00216-019-02170-w) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2019-12-21 2020 /pmc/articles/PMC7118053/ /pubmed/31865417 http://dx.doi.org/10.1007/s00216-019-02170-w Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Paper
Reinicke, Madlen
Dorow, Juliane
Bischof, Karoline
Leyh, Judith
Bechmann, Ingo
Ceglarek, Uta
Tissue pretreatment for LC–MS/MS analysis of PUFA and eicosanoid distribution in mouse brain and liver
title Tissue pretreatment for LC–MS/MS analysis of PUFA and eicosanoid distribution in mouse brain and liver
title_full Tissue pretreatment for LC–MS/MS analysis of PUFA and eicosanoid distribution in mouse brain and liver
title_fullStr Tissue pretreatment for LC–MS/MS analysis of PUFA and eicosanoid distribution in mouse brain and liver
title_full_unstemmed Tissue pretreatment for LC–MS/MS analysis of PUFA and eicosanoid distribution in mouse brain and liver
title_short Tissue pretreatment for LC–MS/MS analysis of PUFA and eicosanoid distribution in mouse brain and liver
title_sort tissue pretreatment for lc–ms/ms analysis of pufa and eicosanoid distribution in mouse brain and liver
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118053/
https://www.ncbi.nlm.nih.gov/pubmed/31865417
http://dx.doi.org/10.1007/s00216-019-02170-w
work_keys_str_mv AT reinickemadlen tissuepretreatmentforlcmsmsanalysisofpufaandeicosanoiddistributioninmousebrainandliver
AT dorowjuliane tissuepretreatmentforlcmsmsanalysisofpufaandeicosanoiddistributioninmousebrainandliver
AT bischofkaroline tissuepretreatmentforlcmsmsanalysisofpufaandeicosanoiddistributioninmousebrainandliver
AT leyhjudith tissuepretreatmentforlcmsmsanalysisofpufaandeicosanoiddistributioninmousebrainandliver
AT bechmanningo tissuepretreatmentforlcmsmsanalysisofpufaandeicosanoiddistributioninmousebrainandliver
AT ceglarekuta tissuepretreatmentforlcmsmsanalysisofpufaandeicosanoiddistributioninmousebrainandliver